Pharvaris (PHVS) Current Taxes (2020 - 2026)
Pharvaris' (PHVS) quarterly Current Taxes came in at $1.1 million in Q1 2026, up 80.02% YoY from $624858.3 in Q1 2025, and up 2.67% on a QoQ basis from $1.1 million in Q4 2025.
Analysis
Pharvaris (PHVS) Current Taxes (2020 - 2026) Analysis & Trends
Pharvaris (PHVS) has 6 years of Current Taxes data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Current Taxes rose 80.02% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 80.02% YoY) and the FY2025 annual result came in at $1.1 million, up 63.41% from the prior year.
- Current Taxes improved to $1.1 million in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $3.0 million in Q2 2022 to a low of $119109.2 in Q2 2024.
- A 5-year average of $746515.4 and a median of $599267.8 in 2025 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2023 — Current Taxes slumped 94.33% — and 2025, when it soared 451.85%.
- Tracing PHVS's Current Taxes over 5 years: stood at $470642.2 in 2022, then slipped by 1.72% to $462570.2 in 2023, then soared by 38.9% to $642489.8 in 2024, then soared by 70.53% to $1.1 million in 2025, then rose by 2.67% to $1.1 million in 2026.
- The last three Current Taxes figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $993121.7 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Pharvaris | 2.10 Bn | 1.73 Bn | 85,072.10 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1,124.86 Bn |
| Dec 31, 2025 | 1,095.61 Bn |
| Sep 30, 2025 | 993,121.65 |
| Jun 30, 2025 | 657,304.09 |
| Mar 31, 2025 | 624,858.28 |
| Dec 31, 2024 | 642.49 Bn |
| Jun 30, 2024 | 119,109.15 |
| Mar 31, 2024 | 573,677.23 |
| Dec 31, 2023 | 462.57 Bn |
| Jun 30, 2023 | 169.76 Bn |
| Mar 31, 2023 | 378,080.36 |
| Dec 31, 2022 | 470.64 Bn |
| Sep 30, 2022 | 388,235.02 |
| Jun 30, 2022 | 2.99 Mn |
| Mar 31, 2022 | 144,460.58 |
| Dec 31, 2021 | 144.32 Bn |
| Dec 31, 2020 | 19,181.56 |